Clinical Course of COVID-19 in a Thalassemia Major Patient who Underwent Haematopoietic Stem Cell Transplantation

dc.authoridHamidi, Aziz Ahmad/0000-0003-4108-0847
dc.authoridULU, YILDIZ/0000-0001-6201-1037
dc.contributor.authorHamidi, Aziz Ahmad
dc.contributor.authorUlu, Yildiz
dc.contributor.authorAktas, Habibullah
dc.date.accessioned2024-09-29T16:06:08Z
dc.date.available2024-09-29T16:06:08Z
dc.date.issued2021
dc.departmentKarabük Üniversitesien_US
dc.description.abstractWe herein reported the course of Coronavirus diasease-19 (COVID-19) in a 21-year-old patient with thalassemia majo rdisease. The patient who underwent haematopoietic stem cell transplantation in 2013 and developed alloimmunization, presented with high fever and weakness. His parents have been recently diagnosed with COVID-19. COVID-19 diagnosis was confirmed by real time-polymerase chain reaction (RT-PCR) method in the nasopharyngeal swab sample of the patient while his thorax computed tomography was not found in favor of pneumonia. The patient was treated with hydroxychloroquine 2x200mg and Favipravir 3x600mg. The temperature fell with in three days. The clinical condition of the patient improved rapidly. On the 20th day. he did not have any symptom with a recovery of anemia and lymphopenia, but the RT-PCR result was stil positive. In this case report, we wanted to point out that the course of the COVID-19 is unexpectedly mild in such a patient with rhalassemia major.en_US
dc.description.sponsorshipAbdi Ibrahim Pharmaceuticalsen_US
dc.description.sponsorshipThis work was supported by Abdi Ibrahim Pharmaceuticals.en_US
dc.identifier.doi10.14235/bas.galenos.2020.4916
dc.identifier.endpage93en_US
dc.identifier.issn2148-2373
dc.identifier.startpage91en_US
dc.identifier.trdizinid425712en_US
dc.identifier.urihttps://doi.org/10.14235/bas.galenos.2020.4916
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/425712
dc.identifier.urihttps://hdl.handle.net/20.500.14619/6639
dc.identifier.volume9en_US
dc.identifier.wosWOS:000616392300019en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofBezmialem Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectthalassemia majoren_US
dc.subjectbeta-thalassemiaen_US
dc.titleClinical Course of COVID-19 in a Thalassemia Major Patient who Underwent Haematopoietic Stem Cell Transplantationen_US
dc.typeArticleen_US

Dosyalar